Research use only · Not for human consumptionPepwizard compares vendor pricing for research-grade compounds. Nothing on this site is medical advice. How we price.
Compound sheet
Fat Loss / Amylin analogue
07.05.2026
FAT LOSSResearch-onlyInvestigationalLow availability
Cagrilintide
Amylin analogue · 32aa · aka "AM-833"
“Amylin side of CagriSema. Satiety play.”
No offers tracked yet.
§ 01 — Spec
Amino acids
32
Half-life
~7 days
Admin
Subcutaneous
Typical dose
2.4 mg subcutaneous weekly (matched to semaglutide)
Live offers
0
§ 02 — Abstract
A long-acting amylin analogue developed by Novo Nordisk. On its own it produces modest weight loss; paired with semaglutide (CagriSema), it exceeds tirzepatide in trials.
Cagrilintide activates amylin and calcitonin receptors, delaying gastric emptying and suppressing appetite through a mechanism complementary to GLP-1 receptor agonism.
Studied for
01Additive weight loss on top of GLP-1
02Targeted appetite suppression
03Extended satiety
04Potential metabolic benefits
§ Codes
Live coupon for Cagrilintide.
§ 03 — Stock
No approved vendor stocks Cagrilintide yet.
We only feature vendors whose affiliate programmes we've signed off — no inventory padding. We're onboarding more partners and will list Cagrilintide as soon as one stocks it.
Email me when it lists
We'll ping you the moment a tracked vendor lists Cagrilintide.
Free · weekly
Your email. That's it. No account. No tracking pixels. Unsubscribe anytime.
§ 04 — Trend
Tracking begins.
We started tracking Cagrilintide on 2026-05-07. The chart unlocks at 14 daily snapshots — currently 1 on file.
1 snapshot · floor on 07.05.2026